Obelab Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Later Stage VC
- Investors
-
11
Obelab General Information
Description
Developer of a brain imaging device designed to make functional near-infrared spectroscopy (fNIRS) technology-based brain monitoring accessible. The company's device is portable and wireless and offers photogrammetry, motion calibration and digital signal processing, enabling medical professionals to monitor concussions, chronic depression, post-traumatic stress disorders (PTSD) and neurorehabilitation.
Contact Information
Website
www.obelab.comCorporate Office
- 12th Floor Vision Tower
- 312, Teheran-ro, Gangnam-gu
- Seoul, 06211
- South Korea
Corporate Office
- 12th Floor Vision Tower
- 312, Teheran-ro, Gangnam-gu
- Seoul, 06211
- South Korea
Obelab Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 01-Nov-2021 | Completed | Generating Revenue | |||
| 4. Grant | 01-Aug-2016 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 01-Feb-2016 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Jan-2015 | $50M | $50M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2014 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Obelab Patents
Obelab Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025220759-A1 | Method and apparatus for prescribing exercise on basis of hemodynamic information, and recording medium | Pending | 15-Apr-2024 | ||
| WO-2024085282-A1 | Method, device, and non-transitory computer-readable recording medium for providing personalized photo-stimulation to improve cognitive functioning | Inactive | 20-Oct-2022 | ||
| WO-2024025035-A1 | Method and device for monitoring effect of photostimulation during photostimulation, and non-transitory computer-readable recording medium | Inactive | 26-Jul-2022 | ||
| US-20230119563-A1 | Method, system, and non-transitory computer-readable recording medium for providing information about post-cardiac arrest prognosis | Pending | 05-Mar-2020 | ||
| WO-2021177797-A1 | Method, system, and non-transitory computer-readable recording medium for providing information about post-cardiac arrest prognosis | Inactive | 05-Mar-2020 | A61B5/7275 |
Obelab Signals
Obelab Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Conar Investment | Venture Capital | Minority | ||
| GU Equity Partners (Korea) | Venture Capital | Minority | ||
| InterValue Partners | Venture Capital | Minority | ||
| Kbridge Ventures | Venture Capital | Minority | ||
| Woori Venture Partners | Venture Capital | Minority |
Obelab FAQs
-
When was Obelab founded?
Obelab was founded in 2013.
-
Where is Obelab headquartered?
Obelab is headquartered in Seoul, South Korea.
-
What is the size of Obelab?
Obelab has 13 total employees.
-
What industry is Obelab in?
Obelab’s primary industry is Monitoring Equipment.
-
Is Obelab a private or public company?
Obelab is a Private company.
-
What is Obelab’s current revenue?
The current revenue for Obelab is .
-
How much funding has Obelab raised over time?
Obelab has raised $53.8M.
-
Who are Obelab’s investors?
Conar Investment, GU Equity Partners (Korea), InterValue Partners, Kbridge Ventures, and Woori Venture Partners are 5 of 11 investors who have invested in Obelab.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process